Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 27, 2007 Rich Duprey	Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note.
Chemistry World August 23, 2013 Jessica Cocker	Plant protein regulates diabetes treatment A plant protein has been used to make a new class of glucose-responsive polymer nanogels that could one day negate the need for diabetes patients to constantly monitor their blood glucose levels and inject themselves with insulin.
Chemistry World August 28, 2015 Jennifer Newton	Synthetic stomach membrane to minimize animal tests Scientists in the UK have made a synthetic surface that could replace animal tissues in liquid drug formulation tests.
Chemistry World February 20, 2014 Laura Howes	Brent Sumerlin: Searching for a sweet response Brent Sumerlin is professor of chemistry at the University of Florida in Gainesville, US. His research concerns the identification, synthesis, and characterization of smart polymers for drug delivery.
Chemistry World July 23, 2012 Jennifer Newton	Delivering insulin in a skin cream Scientists in Japan have developed a way to administer insulin to patients through the skin.
Chemistry World May 7, 2009 Phillip Broadwith	Polymers release insulin in response to glucose trigger Chinese researchers have developed polymer nanoparticles that can release insulin in response to changes in glucose concentration, creating a potential treatment for diabetes.
The Motley Fool June 27, 2005 Stephen D. Simpson	Sniffing Out a Possible Diabetes Blockbuster Inhaled insulin has been a Holy Grail of diabetes care. Will it live up to lofty expectations? Pfizer, Sanofi-Aventis, and Lilly are all interesting in their own right as high-quality pharmaceutical companies, and more aggressive investors should take a look at Nektar and Alkermes, as well.
American Family Physician November 1, 2000	Diabetes: Flexible Insulin Regimens for People with Type 1 Diabetes What is insulin?... How do I use insulin?... What is a flexible insulin regimen?... When should I take insulin?...
Chemistry World February 2, 2015 Megan Tyler	Shock tactics for drug delivery Scientists in India have developed a shock wave-based drug delivery system that could be used to administer insulin in diabetic patients and reduce the need for painful injections.
Nursing November 2009 Christine Kessler	Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia.
Nurse Practitioner May 2011 Stacey A. Seggelke	Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes.
American Family Physician August 1, 2004 Mayfield & White	Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function New insulin preparations and a better understanding of insulin physiology provide more options for family physicians attempting to effectively tailor insulin therapy to the needs of individual patients.
Pharmaceutical Executive March 1, 2006 Ron Feemster	Holding Their Breath: Inhaled Insulin Exubera, Pfizer's inhaled-insulin therapy, is carving out a new market for diabetes drugs. Four more companies are looking for their share.
The Motley Fool May 16, 2007 Mike Havrilla	Nastech Nose Potential The small biotech reports the achievement of positive results for carbetocin nasal spray for the treatment of autism symptoms along with the completion of a $41 million stock offering in January.
American Family Physician January 1, 2003 Jennifer B. Marks	Perioperative Management of Diabetes Diabetic patients who require surgery present special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements.
Chemistry World February 24, 2010 James Urquhart	Buckyball-based gene delivery Japanese researchers have demonstrated effective gene delivery in mice using carbon buckyballs.
IEEE Spectrum January 2011 Sandra Upson	Bionic Pancreas Artificial organ could improve control over diabetes
Managed Care December 2003 Thomas Morrow	Can Amylin Analogue Lead To Better Diabetes Control? Maintaining tight glucose control is difficult to accomplish, but adding amylin to the mix may be the answer.
Chemistry World June 22, 2015 Manisha Lalloo	'Smart patch' set to deliver for diabetes patients A research team has created patches that release insulin in response to changes in oxygen brought about by high glucose levels and hope this could lead to a smarter, painless way of treating the disease.
American Family Physician September 15, 2006 Havas & Donner	Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications.
Chemistry World April 8, 2014 Sarah Kenwright	Olive oil may offer diabetes protection Spanish scientists say increasing the amount of olive oil in your diet could reduce your risk of developing metabolic syndrome and type 2 diabetes.
American Family Physician July 15, 2006 Jennifer D. Goldman-Levine	Insulin Detemir (Levemir) for Diabetes Mellitus Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price.
American Family Physician August 1, 2004	Your Insulin Therapy A patient guide to managing diabetes with insulin.
Bio-IT World August 18, 2004 Mark D. Uehling	I, Virtual Patient Along with a software company specializing in modeling diseases on the computer, Roche Diagnostics is working on creating a new biomarker for diabetes that could be reduced to a simple blood test.
American Family Physician March 15, 2001 Goutham Rao	Insulin Resistance Syndrome Insulin resistance can be linked to diabetes, hypertension, dyslipidemia, cardiovascular disease and other abnormalities. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value...
Reactive Reports Issue 67 David Bradley	Fairytale Insulin Substitute People with type I diabetes could one day be prescribed an extract from pumpkins that will drastically cut their reliance on daily insulin injections.
American Family Physician May 1, 2005	Diabetic Ketoacidosis: What It Is and How to Prevent It An informative patient hand-out on the condition, its causes, triggers, prevention and instructions on what do if the conditions presents.
Chemistry World November 9, 2010 Andrew Turley	Company snapshot: Novo Nordisk As the results for the third quarter of this year roll in, one pharma major - Danish company Novo Nordisk - seems to have done better than most with its diabetes medicines.
Food Processing August 2013 Mark Anthony	The Condemnation of Carbohydrates: A Food Manufacturers Guide to Understanding Diabetes The commonly held notion that sugar intake equals diabetes is a kind of unofficial dogma. But like many dogmas, this one falls apart upon closer examination.
Pharmaceutical Executive May 1, 2009	The Fate of Mannkind Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded?
American Family Physician November 1, 2003 Turok et al.	Management of Gestational Diabetes Mellitus Although the disorder affects approximately 2.5 percent of pregnant women and has been the subject of extensive research, its diagnosis and management continue to be debated.
Managed Care October 2005 Thomas Morrow	Incretin Hormones Poised For Better Control of Diabetes Enhanced management continues due to a greater understanding of the intricate glucose balance and the shortfalls of existing medications.
Managed Care May 2006 Fadia T. Shaya & Deshpande	New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements.
BusinessWeek August 7, 2006 Gene G. Marcial	Emisphere Dances With Giants Tiny biotech Emisphere Technologies has attracted Big Pharma to team up on its products still in clinical trials.
Chemistry World June 16, 2014 Phillip Broadwith	Medtronic to buy Covidien for $43bn The deal continues a theme of consolidation within the medical devices sector, with firms looking to broaden their product and service portfolios.
The Motley Fool October 31, 2007 Brian Lawler	Nastech Still Breathing Coming phase 2 results on four different compounds will help investors assess how well Nastech's nasally-administered drugs might sell. Investors, take note.
Chemistry World December 5, 2007 Jonathan Edwards	Water Cleaning Membrane Shows Hybrid Vigour Scientists in the US have combined naturally-occurring channel proteins with a new polymer to create a membrane that could be used to deliver drugs or purify water.
AskMen.com Alex Santoso	What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it.
Chemistry World March 8, 2007 Jessica Ebert	How to Catch an Insulin-Doping Athlete A growing number of athletes reportedly take insulin to boost their performance illegally, but controlling insulin abuse has gone largely unchecked. Now, a urine test designed by German and Belgian scientists could be set to change all that.
Scientific American December 12, 2005 Philip E. Ross	Grow Your Own Getting a diabetic pancreas to regrow its islets -- growth factors could restore beta cells lost in type 1 diabetes.
Chemistry World August 14, 2008 Jane Qiu	Gel Releases Drugs on Cue A novel gel that delivers drugs in response to a chemical cue may help to make insulin jabs a thing of the past.
Pharmaceutical Executive August 1, 2005	Making Drugs Smarter An interview with Nicholas Peppas on how the world of drug delivery -- at least at its cutting edges -- has begun to converge with diagnostics, tissue design, and materials science in ways that promise to transform some areas of medicine.
Prepared Foods October 1, 2005	The Slow Winner Like the tortoise, Palatinit of America's Palatinose provides an optimal, constant and long-lasting supply of energy in the form of glucose.
Salon.com January 22, 2001 Janet Lafler	I'm a cyborg and I love it My portable insulin pump never strays from my side, but I feel more human with the technology than without it...
AskMen.com April 29, 2001 Joshua Levine	Do You Have Diabetes? Diabetes is not contagious; people cannot "catch" it from one another. However, certain factors can increase one's risk of developing the disease...
The Motley Fool June 24, 2008 Brian Orelli	A Diabetes Drug Delivery Deal Several pharmaceutical companies compete to deliver a diabetes medication that can be taken orally or once-weekly.
The Motley Fool June 29, 2011 Brian Orelli	So Much Insulin, So Little Use for It MannKind settles its supply agreement with Merck.
The Motley Fool January 16, 2008 Brian Lawler	Another Inhalable Insulin Bites the Dust Novo Nordisk discontinues development of its troubled diabetes treatment and settles its patent infringement lawsuit against Pfizer. Investors, take note.
Chemistry World July 30, 2007 James Mitchell Crow	Cell Transplant Hope for Diabetes Sufferers Iron-based 'magnetocapsules' of insulin-producing cells could help doctors use cell transplants to treat type I diabetes.
The Motley Fool July 14, 2006 Stephen D. Simpson	FDA Bloodies Nastech's Nose An FDA rejection for a generic drug is a setback, but not a major one. Experienced biotech investors realize that ideas like Nastech are often binary outcomes -- it's either going to be a big winner or a total flop.